These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8670273)

  • 1. Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse.
    Kuwajima M; Lu K; Harashima H; Ono A; Sato I; Mizuno A; Murakami T; Nakajima H; Miyagawa J; Namba M; Hanafusa T; Hayakawa J; Matsuzawa Y; Shima K
    Biochem Biophys Res Commun; 1996 Jun; 223(2):283-7. PubMed ID: 8670273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary abnormality of carnitine biosynthesis results from carnitine reabsorptional system defect in juvenile visceral steatosis mice.
    Horiuchi M; Kobayashi K; Asaka N; Saheki T
    Biochim Biophys Acta; 1997 Dec; 1362(2-3):263-8. PubMed ID: 9540857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system.
    Horiuchi M; Kobayashi K; Yamaguchi S; Shimizu N; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M; Saheki T
    Biochim Biophys Acta; 1994 Apr; 1226(1):25-30. PubMed ID: 8155735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency.
    Hashimoto N; Suzuki F; Tamai I; Nikaido H; Kuwajima M; Hayakawa J; Tsuji A
    Biochem Pharmacol; 1998 May; 55(10):1729-32. PubMed ID: 9634010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice.
    Yokogawa K; Yonekawa M; Tamai I; Ohashi R; Tatsumi Y; Higashi Y; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Nezu J; Oku A; Shimane M; Miyamoto K; Tsuji A
    Hepatology; 1999 Oct; 30(4):997-1001. PubMed ID: 10498652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
    Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
    J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
    Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
    FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
    Nakajima T; Horiuchi M; Yamanaka H; Kizaki Z; Inoue F; Kodo N; Kinugasa A; Saheki T; Sawada T
    Pediatr Res; 1997 Jul; 42(1):108-13. PubMed ID: 9212045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.
    Higashi Y; Yokogawa K; Takeuchi N; Tamai I; Nomura M; Hashimoto N; Hayakawa JI; Miyamoto KI; Tsuji A
    J Pharm Pharmacol; 2001 Apr; 53(4):527-33. PubMed ID: 11341370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the feeding response to fasting in carnitine-deficient juvenile visceral steatosis (JVS) mice: involvement of defective acyl-ghrelin secretion and enhanced corticotropin-releasing factor signaling in the hypothalamus.
    Sakoguchi T; Horiuchi M; Asakawa A; Ushikai M; Yoshida G; Fujimiya M; Kato I; Nakazato M; Takeuchi T; Saheki T; Inui A
    Biochim Biophys Acta; 2009 Nov; 1792(11):1087-93. PubMed ID: 19744557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.
    Knapp AC; Todesco L; Torok M; Beier K; Krähenbühl S
    Ann Nutr Metab; 2008; 52(2):136-44. PubMed ID: 18417958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
    Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
    Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
    Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
    Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
    Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal gene expression causing hyperammonemia in carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Saheki T; Tomomura M; Horiuchi M; Imamura Y; Tomomura A; Abdullah Abue Musa D; Kobayashi K
    Adv Exp Med Biol; 1997; 420():159-72. PubMed ID: 9286432
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis.
    Kuwajima M; Kono N; Horiuchi M; Imamura Y; Ono A; Inui Y; Kawata S; Koizumi T; Hayakawa J; Saheki T
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1090-4. PubMed ID: 1996978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia in carnitine-deficient adult JVS mice used by starvation.
    Li XX; Kobayashi K; Horiuchi M; Jalil A; Yoshida G; Saheki T
    Metab Brain Dis; 2002 Dec; 17(4):359-66. PubMed ID: 12602512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.